Basic Information
RNALocate ID: | RLID:01001460 |
RNA Symbol: | hsa-miR-103a-3p |
Localization: | Mitochondrion |
RNA Information
RNA Name: | hsa-miR-103a |
RNA ID: | miRBase:MIMAT0000101 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22984580 |
Tissue/Cell Line: | Cell line (HEK-293|HeLa) |
Method: | Next-generation RNA sequencing |
Description: | The differential association of miRNA to mitochondria of both HEK293 and HeLa has been summarized in Table S3. Data are collected from Table S3: Pattern of miRNAs associated with mitochondria of HEK293 and HeLa. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001454 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001455 | Cytoplasm | Neural progenitor cells | 21363885 |
RLID:01001456 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001457 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001458 | Mitochondrion | Myotube|Osteosarcoma cell line (143B) | 27396686 |
RLID:01001459 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001461 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001462 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001463 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001464 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11001017 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
RLID:11001018 | Exosome | Pooled sera | 27278097 |
RLID:11001019 | Exosome | Serum | 18589210 |
RLID:11001020 | Exosome | Peripheral blood mononuclear cells | 19002258 |
RLID:11001021 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11001022 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001023 | Exosome | Brain tissue | 23382797 |
RLID:11001024 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001025 | Microvesicle | Plasma | 19002258 |
RLID:11001026 | Microvesicle | Plasma | 23077538 |
RLID:11001027 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001028 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000035 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000300 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-103a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-02946 |
MNDR | hsa-miR-103a-3p | Oral squamous cell carcinoma | MNDR-E-MI-02947 |
MNDR | hsa-miR-103a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-02948 |
MNDR | hsa-miR-103a-3p | Medulloblastoma | MNDR-E-MI-02949 |
MNDR | hsa-miR-103a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-02950 |
MNDR | hsa-miR-103a-3p | Ovarian clear cell carcinoma | MNDR-E-MI-02951 |
MNDR | hsa-miR-103a-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-02952 |
MNDR | hsa-miR-103a-3p | Lymphoma | MNDR-E-MI-02953 |
MNDR | hsa-miR-103a-3p | Lymphoma non-hodgkin | MNDR-E-MI-02954 |
MNDR | hsa-miR-103a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-02955 |
MNDR | hsa-miR-103a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-02956 |
MNDR | hsa-miR-103a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-02957 |
MNDR | hsa-miR-103a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-02958 |
MNDR | hsa-miR-103a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-02959 |
MNDR | hsa-miR-103a-3p | Breast cancer luminal | MNDR-E-MI-02960 |
MNDR | hsa-miR-103a-3p | Anencephaly | MNDR-E-MI-02961 |
MNDR | hsa-miR-103a-3p | Niemann-pick disease type c | MNDR-E-MI-02962 |
MNDR | hsa-miR-103a-3p | Neurofibromatosis 1 | MNDR-E-MI-02963 |
MNDR | hsa-miR-103a-3p | Dermatomyositis | MNDR-E-MI-02964 |
MNDR | hsa-miR-103a-3p | Prostate cancer | MNDR-E-MI-02965 |
MNDR | hsa-miR-103a-3p | Gastric cancer | MNDR-E-MI-02966 |
MNDR | hsa-miR-103a-3p | Gastric lymphoma | MNDR-E-MI-02967 |
MNDR | hsa-miR-103a-3p | Alzheimer disease | MNDR-E-MI-02968 |
MNDR | hsa-miR-103a-3p | Intracranial aneurysm | MNDR-E-MI-02969 |
MNDR | hsa-miR-103a-3p | Bladder cancer | MNDR-E-MI-02970 |
MNDR | hsa-miR-103a-3p | Esophageal carcinoma | MNDR-E-MI-02971 |
MNDR | hsa-miR-103a-3p | Dysautonomia familial | MNDR-E-MI-02972 |
MNDR | hsa-miR-103a-3p | Head and neck cancer | MNDR-E-MI-02973 |
MNDR | hsa-miR-103a-3p | Malaria | MNDR-E-MI-02974 |
MNDR | hsa-miR-103a-3p | Leukemia | MNDR-E-MI-02975 |
MNDR | hsa-miR-103a-3p | Huntington disease | MNDR-E-MI-02976 |
MNDR | hsa-miR-103a-3p | Chorea | MNDR-E-MI-02977 |
MNDR | hsa-miR-103a-3p | Cardiovascular disease | MNDR-E-MI-02978 |
MNDR | hsa-miR-103a-3p | Carotid stenosis | MNDR-E-MI-02979 |
MNDR | hsa-miR-103a-3p | Moyamoya disease | MNDR-E-MI-02980 |
MNDR | hsa-miR-103a-3p | Lung cancer | MNDR-E-MI-02981 |
MNDR | hsa-miR-103a-3p | Endometrial cancer | MNDR-E-MI-02982 |
MNDR | hsa-miR-103a-3p | Parkinson disease | MNDR-E-MI-02983 |
MNDR | hsa-miR-103a-3p | Niemann-pick disease | MNDR-E-MI-02984 |
MNDR | hsa-miR-103a-3p | Basal-like breast cancer | MNDR-E-MI-02985 |
MNDR | hsa-miR-103a-3p | Thyroid cancer | MNDR-E-MI-02986 |
MNDR | hsa-miR-103a-3p | Pituitary neoplasms | MNDR-E-MI-02987 |
MNDR | hsa-miR-103a-3p | Malignant mesothelioma | MNDR-E-MI-02988 |
MNDR | hsa-miR-103a-3p | Pancreatic cancer | MNDR-E-MI-02989 |
MNDR | hsa-miR-103a-3p | Melanoma | MNDR-E-MI-02990 |
MNDR | hsa-miR-103a-3p | Nephroblastoma | MNDR-E-MI-02991 |
MNDR | hsa-miR-103a-3p | Colon cancer | MNDR-E-MI-02992 |
MNDR | hsa-miR-103a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-02993 |
MNDR | hsa-miR-103a-3p | Prostate adenocarcinoma | MNDR-E-MI-02994 |
MNDR | hsa-miR-103a-3p | Cerebellar disease | MNDR-E-MI-02995 |
MNDR | hsa-miR-103a-3p | Carcinoma ductal breast | MNDR-E-MI-02996 |
MNDR | hsa-miR-103a-3p | Glioblastoma | MNDR-E-MI-02997 |
MNDR | hsa-miR-103a-3p | Glioma | MNDR-E-MI-02998 |
MNDR | hsa-miR-103a-3p | Chordoma | MNDR-E-MI-02999 |
MNDR | hsa-miR-103a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-03000 |
MNDR | hsa-miR-103a-3p | Epilepsy temporal lobe | MNDR-E-MI-03001 |
MNDR | hsa-miR-103a-3p | Osteosarcoma | MNDR-E-MI-03002 |
MNDR | hsa-miR-103a-3p | Inclusion body myositis | MNDR-E-MI-03003 |
MNDR | hsa-miR-103a-3p | Meningioma | MNDR-E-MI-03004 |
MNDR | hsa-miR-103a-3p | Liver cancer | MNDR-E-MI-03005 |
MNDR | hsa-miR-103a-3p | Uterine cancer | MNDR-E-MI-03006 |
MNDR | hsa-miR-103a-3p | Gastric adenocarcinoma | MNDR-E-MI-03007 |
MNDR | hsa-miR-103a-3p | Pituitary adenoma | MNDR-E-MI-03008 |
MNDR | hsa-miR-103a-3p | Lung squamous cell carcinoma | MNDR-E-MI-03009 |
MNDR | hsa-miR-103a-3p | Carcinoma lung non-small-cell | MNDR-E-MI-03010 |
MNDR | hsa-miR-103a-3p | Lung adenocarcinoma | MNDR-E-MI-03011 |
MNDR | hsa-miR-103a-3p | Adrenocortical cancer | MNDR-E-MI-03012 |
MNDR | hsa-miR-103a-3p | Thyroid carcinoma | MNDR-E-MI-03013 |
MNDR | hsa-miR-103a-3p | Ovarian carcinoma | MNDR-E-MI-03014 |
MNDR | hsa-miR-103a-3p | Bladder urothelial carcinoma | MNDR-E-MI-03015 |
MNDR | hsa-miR-103a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-03016 |
MNDR | hsa-miR-103a-3p | Carcinoma renal cell | MNDR-E-MI-03017 |
MNDR | hsa-miR-103a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-03018 |
MNDR | hsa-miR-103a-3p | Renal clear cell carcinoma | MNDR-E-MI-03019 |
MNDR | hsa-miR-103a-3p | Cholangiocarcinoma | MNDR-E-MI-03020 |
MNDR | hsa-miR-103a-3p | Esophageal cancer | MNDR-E-MI-03021 |
MNDR | hsa-miR-103a-3p | Liver cirrhosis | MNDR-E-MI-03022 |
MNDR | hsa-miR-103a-3p | Lung small cell carcinoma | MNDR-E-MI-03023 |
MNDR | hsa-miR-103a-3p | Encephalopathy bovine spongiform | MNDR-E-MI-03024 |
MNDR | hsa-miR-103a-3p | Synovial sarcoma | MNDR-E-MI-03025 |
MNDR | hsa-miR-103a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-03026 |
MNDR | hsa-miR-103a-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-03027 |
MNDR | hsa-miR-103a-3p | Fibromyalgia | MNDR-E-MI-03028 |
MNDR | hsa-miR-103a-3p | Encephalomyelitis | MNDR-E-MI-03029 |
MNDR | hsa-miR-103a-3p | Breast invasive carcinoma | MNDR-E-MI-03030 |
MNDR | hsa-miR-103a-3p | Hepatocellular carcinoma | MNDR-E-MI-03031 |
MNDR | hsa-miR-103a-3p | B-cell lymphoma | MNDR-E-MI-03032 |
MNDR | hsa-miR-103a-3p | Rheumatoid arthritis | MNDR-E-MI-03033 |
MNDR | hsa-miR-103a-3p | T-cell leukemia | MNDR-E-MI-03034 |
MNDR | hsa-miR-103a-3p | Retinoblastoma | MNDR-E-MI-03035 |
MNDR | hsa-miR-103a-3p | Neuroblastoma | MNDR-E-MI-03036 |
MNDR | hsa-miR-103a-3p | Chronic fatigue syndrome | MNDR-E-MI-03037 |
MNDR | hsa-miR-103a-3p | Hodgkin lymphoma | MNDR-E-MI-03038 |
MNDR | hsa-miR-103a-3p | Burkitt lymphoma | MNDR-E-MI-03039 |
MNDR | hsa-miR-103a-3p | Dementia vascular | MNDR-E-MI-03040 |
MNDR | hsa-miR-103a-3p | Tonsil cancer | MNDR-E-MI-03041 |
MNDR | hsa-miR-103a-3p | Acute myeloid leukemia | MNDR-E-MI-03042 |
MNDR | hsa-miR-103a-3p | Colorectal cancer | MNDR-E-MI-03043 |
MNDR | hsa-miR-103a-3p | Nasopharynx carcinoma | MNDR-E-MI-03044 |
MNDR | hsa-miR-103a-3p | Multiple myeloma | MNDR-E-MI-03045 |
MNDR | hsa-miR-103a-3p | Ovarian epithelial cancer | MNDR-E-MI-03046 |
MNDR | hsa-miR-103a-3p | Cardiomegaly | MNDR-E-MI-03047 |
MNDR | hsa-miR-103a-3p | Nasopharyngeal cancer | MNDR-E-MI-03048 |
MNDR | hsa-miR-103a-3p | Prostatic neoplasms | MNDR-E-MI-03049 |
MNDR | hsa-miR-103a-3p | Pseudorabies | MNDR-E-MI-03050 |
MNDR | hsa-miR-103a-3p | Sleep deprivation | MNDR-E-MI-03051 |
MNDR | hsa-miR-103a-3p | Epstein-barr virus infections | MNDR-E-MI-03052 |
MNDR | hsa-miR-103a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-03053 |
MNDR | hsa-miR-103a-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-03054 |
MNDR | hsa-miR-103a-3p | Venous thromboembolism | MNDR-E-MI-03055 |
MNDR | hsa-miR-103a-3p | Stroke lacunar | MNDR-E-MI-03056 |
MNDR | hsa-miR-103a-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-03057 |
MNDR | hsa-miR-103a-3p | Breast cancer her3+ negative | MNDR-E-MI-03058 |
MNDR | hsa-miR-103a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-03059 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AADAT | Homo sapiens | RR00020840 |
TOP